Donna Rackley
Psychiatric/Mental Health · Greenville, NCNPI 1801873583
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 287 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by AbbVie at 25.8% of the total. Among psychiatric/mental health clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 287 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$613
- Axsome Therapeutics, Inc.$505
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$453
- Vanda Pharmaceuticals Inc.$381
- Alkermes, Inc.$355
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,334100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 80 | $1,634 |
| Johnson & Johnson | 18 | $613 |
| Axsome Therapeutics, Inc. | 15 | $505 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 20 | $453 |
| Vanda Pharmaceuticals Inc. | 21 | $381 |
| Alkermes, Inc. | 13 | $355 |
| Otsuka America Pharmaceutical, Inc. | 12 | $346 |
| Teva Pharmaceuticals USA, Inc. | 12 | $286 |
| Lundbeck LLC | 12 | $240 |
| Neurocrine Biosciences, Inc. | 10 | $237 |
| Supernus Pharmaceuticals, Inc. | 13 | $209 |
| Idorsia Pharmaceuticals US Inc | 13 | $184 |
| E.r. Squibb & Sons, L.L.C. | 2 | $143 |
| Corium, LLC | 6 | $129 |
| Neos Therapeutics, LP | 7 | $125 |
| Sunovion Pharmaceuticals Inc. | 9 | $83 |
| Bausch Health US, LLC | 4 | $79 |
| Merck | 5 | $76 |
| Almatica Pharma LLC | 4 | $57 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $45 |
| Brainsway USA Inc | 2 | $39 |
| Biogen | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Eisai Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $16 |
| Acadia Pharmaceuticals Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,334 in reported general payments places this provider in the 90th percentile of 947 psychiatric/mental health providers in North Carolina.
See all psychiatric/mental health providers in North Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 16 | $33,317 |
| TrintellixVortioxetine Hydrobromide | 12 | $9,265 |
| Prazosin Hcl | 16 | $1,220 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 20 | $994 |
| Bupropion XlBupropion Hcl | 45 | $930 |
| Trazodone Hcl | 65 | $904 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 27 | $498 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $389 |
| Lamotrigine | 31 | $306 |
| Mirtazapine | 20 | $267 |
| Hydroxyzine Pamoate | 20 | $197 |
| Escitalopram Oxalate | 24 | $187 |
| Sertraline Hcl | 16 | $127 |
| Alprazolam | 12 | $69 |
| Clonazepam | 17 | $52 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $346 | $33,31716 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $45 | $9,26512 claims |
| Almatica Pharma LLCSertraline Hcl | $57 | $12716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 947 psychiatric/mental health providers in North Carolina.
Other psychiatric/mental health in Greenville
- Maria Teresa AlexanderGreenville$12K
- Heriberto SierraGreenville$7K
- Desiree MatthewsCharlotte$807K
- Benedetto PalomboCharlotte$671K
- Clarence RunnelsCreedmoor$339K
- Lisa SuddrethGastonia$111K
- April NandigamGreensboro$88K
- Hannah NealeyFuquay Varina$75K
- Jessica StoneRocky Mount$63K
- Deborah GranickRaleigh$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.